Potential and emerging treatment options for Ebola virus disease.
about
Ebola virus disease and critical illness.Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agentsAddressing Therapeutic Options for Ebola Virus Infection in Current and Future OutbreaksEbola: a holistic approach is required to achieve effective management and controlPre-symptomatic diagnosis and treatment of filovirus diseasesEmerging causes of viral-associated uveitisHunting Viral Receptors Using Haploid CellsMolecular pharming's foot in the FDA's door: Protalix's trailblazing storyVirtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infectionEbola virus - from neglected threat to global emergency state.Molecular farming on rescue of pharma industry for next generations.Ebola: Implications and Perspectives.Discovery of an antibody for pan-ebolavirus therapyThe Ebola Outbreak of 2014-2015: From Coordinated Multilateral Action to Effective Disease Containment, Vaccine Development, and Beyond.Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak.Small molecules with antiviral activity against the Ebola virusLipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates.Fast track antibody V-gene rescue, recombinant expression in plants and characterization of a PfMSP4-specific antibody.Ebola virus disease: what canadian hospital pharmacists need to knowAntiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.Lack of protection against ebola virus from chloroquine in mice and hamstersImproving attrition rates in Ebola virus drug discovery.Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic ImplicationsMechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.China takes an active role in combating an Ebola outbreak: On-site observations and reflections from a Chinese healthcare provider.Ebola Virus Infection: Overview and Update on Prevention and Treatment.Ebola virus disease.Critical Care for Multiple Organ Failure Secondary to Ebola Virus Disease in the United States.Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells.Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.Ebola virus outbreak, updates on current therapeutic strategies.Development of Small-Molecule Antivirals for Ebola.Ethical challenges to responding to the Ebola epidemic: the World Health Organization experience.Ebola virus disease: emergence, outbreak and future directions.Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds.Clinical research during the Ebola virus disease outbreak in Guinea: Lessons learned and ways forward.Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseasesEbola virus disease: Essential clinical knowledge.Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014.Distinguishing professionalism and heroism when disaster strikes.
P2860
Q26250274-E96E9530-8B64-4B0B-A593-EFE9B62FBCA1Q26783107-A5E6837A-8C0F-47FD-BF65-A3070B4314B8Q26801423-6E705684-4D4A-4443-8C9F-B5FB16E69217Q26823792-1DBEED11-997F-4B4C-89E0-996CE20080EBQ26823831-2B6F01BC-AAB6-4F38-894E-029E93766BC9Q26830020-2D25203B-7275-4977-8347-D1E0FDA74154Q28080327-A86F0431-F382-4EEC-AD34-5B1B9D6F1923Q28086959-91770B6D-3F49-45D5-87F4-B18242FB8E73Q28649882-549480F5-47C9-4500-805C-1630EBB18A2DQ30245153-2B0331E8-646C-45A6-9B1B-4DFD240AB33BQ30252148-B4675CC8-BBAC-49F2-8DE8-0D4934EC53B2Q30378672-78681B2D-3196-4F0E-B369-BE94811BC2B2Q30385927-B1FD3E31-B195-488F-9643-975AF9D541C7Q30386387-AE9B2AAB-4C52-40A9-8BE6-10BC2F783EB7Q33825309-42C7E1F9-09D9-4795-8A66-0404A5D22990Q34464403-A582653C-B12E-4471-AB27-99EAA9927C2EQ34473079-C2BAB17E-D29A-474D-B341-FBA00129FF0BQ35068156-EC6F2765-DC2F-430B-B20E-2C3B4629DC83Q35551653-16380BD0-EE47-49BC-9B78-5E9099F1BBBBQ35605579-CAA17E1B-CC95-4A75-AB37-FED6C18A08EEQ35673457-E49166A0-A85A-436F-94DE-058D92F33ED2Q35678774-9561595C-5D04-45F7-87F9-7EBE541917E4Q35784542-C3E480C7-C234-4759-A280-C52A9899AADBQ36208191-784D6BBB-3DC4-47CD-8A1A-34CE039CD327Q36322070-FFF59ACD-E15D-4350-AFDB-5E1C1419D846Q36363253-AC352FC3-CF0A-4391-81E3-19378EC2E831Q36449434-FA0BDD67-93F6-4310-BE9A-3E22FBC017F7Q37058235-C2226177-30BB-470C-97D4-D2576F103A60Q37433779-42109F32-9268-4F71-8895-1ACB0F6426FCQ38360827-25A541FD-7872-4A71-8EF7-D7347BB99DC9Q38473251-2212B41D-A0A3-4C8F-868D-049BDF03EF45Q38546746-B8F91D47-D0FC-489A-9411-B0D982983D21Q38697018-F4777514-6FFC-4683-8569-60A1633AAD2AQ38731580-6B4C6715-B1D7-4855-B9D5-442A466EE032Q38820461-68BE6B13-1BF3-4ACC-9D84-B89A726D426DQ38898706-E702A155-32C4-43B6-A068-B8C1AB981917Q39360987-9969A288-ED8D-4193-9B06-B221E655A5D3Q40044063-6C749D8E-9D38-4FAE-93AB-762B50B1D417Q40082843-B965F1D1-6682-4986-9C69-8D43F17EC568Q40139669-3CEE0ED4-ADF0-49F1-9C4F-31201251ADBD
P2860
Potential and emerging treatment options for Ebola virus disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Potential and emerging treatment options for Ebola virus disease.
@en
type
label
Potential and emerging treatment options for Ebola virus disease.
@en
prefLabel
Potential and emerging treatment options for Ebola virus disease.
@en
P2860
P356
P1476
Potential and emerging treatment options for Ebola virus disease.
@en
P2093
Bryan M Bishop
P2860
P304
P356
10.1177/1060028014561227
P407
P577
2014-11-20T00:00:00Z